Página inicialGruposDiscussãoMaisZeitgeist
Pesquise No Site
Este site usa cookies para fornecer nossos serviços, melhorar o desempenho, para análises e (se não estiver conectado) para publicidade. Ao usar o LibraryThing, você reconhece que leu e entendeu nossos Termos de Serviço e Política de Privacidade . Seu uso do site e dos serviços está sujeito a essas políticas e termos.

Resultados do Google Livros

Clique em uma foto para ir ao Google Livros

Carregando...

The Billion Dollar Molecule: One Company's Quest for the Perfect Drug

de Barry Werth

MembrosResenhasPopularidadeAvaliação médiaMenções
1563175,507 (4.07)3
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing -- atom by atom -- both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS. You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.… (mais)
Carregando...

Registre-se no LibraryThing tpara descobrir se gostará deste livro.

Ainda não há conversas na Discussão sobre este livro.

» Veja também 3 menções

Exibindo 3 de 3
Way too much nitty gritty detail for a lay reader. If you were involved in this company or a scientist you might enjoy it more than I did. ( )
  BrendaRT20 | Sep 3, 2023 |
Werth's book about a company's inception and its revolutionary use of rational drug design should be required reading for all in the sciences. It highlights to amazing extents the pros and cons of academia and industry, and as a current PhD student, I can fully relate to the issues. The scientific struggles of publishing and politics are all excruciatingly detailed, and you're left in awe of the immense strength and will of the characters. Werth's prose is riveting as well. I wish there were a more recent book of equal calibre, detailing maybe a company's trials in genomic medicine. ( )
  bsmashers | Aug 1, 2020 |
A very interesting story of a pharmaceutical startup. So much hype, with no solid basis, and yet they survive. Werth does a good job explaining the business, the science, and the experience of doing the science.

> Scientists, unlike, say, athletes, conjure their own competition. They seldom know precisely whom they’re competing with or where they are in the race. They hear things—rumors, reports—but the information comes at a distance and with a price: It may be exaggerated, deliberately misleading, or simply false. The atmosphere in a lab in the throes of a heated project is insular, secretive, xenophobic, superheated, and paranoid.

> "There's two situations where you want to be aggressive about publishing. One is when you're behind; the other is when you're ahead. When you're ahead, you demoralize the other guy. When you're behind, you have nothing to lose. It's when you don't know that you want to be most careful." ( )
  breic | Aug 2, 2019 |
Exibindo 3 de 3
sem resenhas | adicionar uma resenha
Você deve entrar para editar os dados de Conhecimento Comum.
Para mais ajuda veja a página de ajuda do Conhecimento Compartilhado.
Título canônico
Título original
Títulos alternativos
Data da publicação original
Pessoas/Personagens
Lugares importantes
Eventos importantes
Filmes relacionados
Epígrafe
Dedicatória
Primeiras palavras
Informação do Conhecimento Comum em inglês. Edite para a localizar na sua língua.
Squatting between the twin towers of the World Trade Center in New York City, the Vista International Hotel is a minor cultural monument of the 1980s.
Citações
Últimas palavras
Informação do Conhecimento Comum em inglês. Edite para a localizar na sua língua.
(Clique para mostrar. Atenção: Pode conter revelações sobre o enredo.)
Aviso de desambiguação
Editores da Publicação
Autores Resenhistas (normalmente na contracapa do livro)
Idioma original
CDD/MDS canônico
LCC Canônico

Referências a esta obra em recursos externos.

Wikipédia em inglês (2)

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing -- atom by atom -- both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS. You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.

Não foram encontradas descrições de bibliotecas.

Descrição do livro
Resumo em haiku

Current Discussions

Nenhum(a)

Capas populares

Links rápidos

Avaliação

Média: (4.07)
0.5
1
1.5
2 1
2.5 1
3
3.5 1
4 7
4.5
5 5

É você?

Torne-se um autor do LibraryThing.

 

Sobre | Contato | LibraryThing.com | Privacidade/Termos | Ajuda/Perguntas Frequentes | Blog | Loja | APIs | TinyCat | Bibliotecas Históricas | Os primeiros revisores | Conhecimento Comum | 205,207,787 livros! | Barra superior: Sempre visível